Amphastar Pharmaceuticals, Inc. (AMPH) › Net IncomeAmphastar Pharmaceuticals, Inc. (AMPH) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: $18.09M2013: $11.86M2014: -$10.70M2015: -$2.79M2016: $9.82M2017: $3.65M2018: -$5.74M2019: $48.94M2020: $1.40M2021: $62.12M2022: $91.39M2023: $137.54M2024: $159.52M2025: $98.09M$98.09M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$98.09M-38.5%2024$159.52M+16.0%2023$137.54M+50.5%2022$91.39M+47.1%2021$62.12M+4327.4%2020$1.40M-97.1%2019$48.94M+952.9%2018-$5.74M-257.3%2017$3.65M-62.9%2016$9.82M+452.4%2015-$2.79M+74.0%2014-$10.70M-190.2%2013$11.86M-34.4%2012$18.09M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share